文献速递腹部技术与安全CT

超重及肥胖患者腹部增强CT中光子计数探测器CT与第二代双源能量积分探测器CT采用减量对比剂方案的图像质量比较

Reduced versus standard dose contrast volume for contrast-enhanced abdominal CT in overweight and obese patients using photon counting detector technology vs. second-generation dual-source energy integrating detector CT.
PubMed 文献 · Eur J Radiol · 2023-10-18

前瞻性纳入68例BMI≥25且既往已行第二代双源能量积分探测器CT(DS-EID-CT)腹部增强CT的超重/肥胖患者,在同一代光子计数探测器CT(DS-PCD-CT)上以1.2 mL/kg对比剂行第二次检查,对比剂目标体积较前次0.8 mL/kg方案不同。结果显示DS-PCD-CT在QIR 3水平下实质器官与血管SNR均高于DS-EID-CT,两名放射科医师对DS-PCD-CT图像质量评分更高(p<0.05),且CTDIvol与DLP显著低于DS-EID-CT(p<0.001)。

要点

  • DS-PCD-CT在QIR 3水平下实质器官SNR为12.61,高于QIR 2的11.47和DS-EID-CT的10.53。
  • DS-PCD-CT血管SNR为16.73,高于QIR 2的14.20和DS-EID-CT的12.07。
  • QIR 3中位噪声与DS-EID-CT相同(8.65 vs 8.65),两名医师对DS-PCD-CT图像质量评分更高(p<0.05)。

核心结论

  • 使用第一代DS-PCD-CT行腹部增强CT可在维持图像质量的同时显著降低对比剂体积和辐射剂量(DLP降低27%、CTDIvol降低31%)。

研究设计与样本

  • 前瞻性研究,纳入68例BMI≥25 kg/m²、临床需要行门静脉期腹部增强CT的患者,均已在第二代DS-EID-CT上按标准方案完成过检查,随后在商用第一代DS-PCD-CT上复查;两次检查均采用双能量模式,对比剂体积按体重调整(第一次研究目标1.2 mL/kg,第二次研究目标0.8 mL/kg),重建多色图像及40 keV、70 keV虚拟单能图像(DS-PCD-CT数据称为T3D)。

关键影像表现/征象

  • DS-PCD-CT在QIR 3水平下实质器官SNR为12.61,QIR 2为11.47,DS-EID-CT为10.53。
  • DS-PCD-CT血管SNR为16.73,QIR 2为14.20,DS-EID-CT为12.07。
  • QIR 3水平中位噪声与DS-EID-CT相同(8.65 vs 8.65)。
  • 两台扫描仪均在40 keV时获得最高CNR。
  • T3D的SNR显著高于40 keV和70 keV,噪声水平更低。

诊断标准与关键数值

  • 主观图像质量采用5点Likert量表评估,两名放射科医师对DS-PCD-CT数据集的评分更高(p<0.05)。
  • DS-PCD-CT的CTDIvol中位数为10.90 mGy(IQR 9.31–12.50 mGy),DS-EID-CT为16.55 mGy(IQR 15.45–18.17 mGy)。
  • DS-PCD-CT的DLP中位数为589.50 mGy·cm(IQR 498.50–708.25 mGy·cm),DS-EID-CT为848.75 mGy·cm(IQR 753.43–969.58 mGy·cm)(p<0.001)。
  • 肥胖分级依据BMI:超重25–29.9、肥胖I级30–34.9、肥胖II级35–39.9、肥胖III级>40;本组超重10例(14.7%)、肥胖I级38例(55.9%)、II级13例(19.1%)、III级7例(10.3%)。

临床应用与阅片要点

  • 对于BMI≥25的超重及肥胖患者,第一代DS-PCD-CT可在降低对比剂体积和辐射剂量的条件下维持腹部增强CT诊断图像质量。
  • DS-PCD-CT的多色重建T3D可提供满足肿瘤成像诊断需求的图像质量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare image quality of contrast-enhanced abdominal-CT using 1st-generation Dual Source Photon-Counting Detector CT (DS-PCD-CT) versus 2nd-generation Dual-Source Energy Integrating-Detector CT (DS-EID-CT) in patients with BMI ≥ 25, applying two different contrast agent volumes, vendor proposed protocols and different virtual monoenergetic images (VMI).

METHOD: 68 overweight (BMI ≥ 25 kgm2) patients (median age: 65 years; median BMI 33.3 kgm2) who underwent clinically indicated, portal-venous contrast-enhanced abdominal-CT on a commercially available 1st-generation DS-PCD-CT were prospectively included if they already have had a pre-exam on 2nd-generation DS-EID-CT using a standardized exam protocol. Obesity were defined by BMI-calculation (overweight: 25-29.9, obesity grade I: 30-34.9; obesity grade II: 35-39.9; obesity grade III: > 40) and by the absolute weight value. Body weight adapted contrast volume (targeted volume of 1.2 mL/kg for the 1st study and 0.8 mL/kg for the 2nd study) was applied in both groups. Dual Energy mode was used for both the DS-PCD-CT and the DS-EID-CT. Polychromatic images and VMI (40 keV and 70 keV) were reconstructed for both the DS-EID-CT and the DS-PCD-CT data (termed T3D). Two radiologists assessed subjective image quality using a 5-point Likert-scale. Each reader drew ROIs within parenchymatous organs and vascular structures to analyze image noise, contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR).

RESULTS: Median time interval between scans was 12 months (Min: 6 months; Max: 36 months). BMI classification included overweight (n = 10, 14.7 %), obesity grade I (n = 38, 55.9 %), grade II (n = 13, 19.1 %) and grade III (n = 7, 10.3 %). The SNR achieved with DS-PCD-CT at QIR level 3was 12.61 vs. 11.47 (QIR 2) vs. 10.53 (DS-EID-CT), irrespective of parenchymatous organs. For vessels, the SNR were 16.73 vs. 14.20 (QIR 2) vs. 12.07 (DS-EID-CT). Moreover, the obtained median noise at QIR level 3 was as low as that of the DS-EID-CT (8.65 vs. 8.65). Both radiologists rated the image quality higher for DS-PCD-CT data sets (p < 0.05). The highest CNR was achieved at 40 keV for both scanners. T3D demonstrated significantly higher SNR and lower noise level compared to 40 keV and 70 keV. Median CTDIvol and DLP values for DS-PCD-CT and DS-EID-CT were 10.90 mGy (IQR: 9.31 - 12.50 mGy) vs. 16.55 mGy (IQR: 15.45 - 18.17 mGy) and 589.50 mGy * cm (IQR: 498.50 - 708.25 mGy * cm) vs. 848.75 mGy * cm (IQR: 753.43 - 969.58 mGy * cm) (p < 0.001).

CONCLUSION: Image quality can be maintained while significantly reducing the contrast volume and the radiation dose (27% and 34% lower DLP and 31% lower CDTIvol) for abdominal contrast-enhanced CT using a 1st-generation DS-PCD-CT. Moreover, polychromatic reconstruction T3D on a DS-PCD-CT enables sufficient diagnostic image quality for oncological imaging.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Hagen F, Estler A, Hofmann J, et al. Reduced versus standard dose contrast volume for contrast-enhanced abdominal CT in overweight and obese patients using photon counting detector technology vs. second-generation dual-source energy integrating detector CT. Eur J Radiol. 2023. PMID: 38250749. doi:10.1016/j.ejrad.2023.111153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。